A detailed history of Stifel Financial Corp transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Stifel Financial Corp holds 43,128 shares of CRSP stock, worth $1.89 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,128
Previous 40,237 7.18%
Holding current value
$1.89 Million
Previous $1.89 Million 10.21%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$38.65 - $55.15 $111,737 - $159,438
2,891 Added 7.18%
43,128 $1.7 Million
Q3 2024

Nov 14, 2024

SELL
$44.62 - $62.75 $454,008 - $638,481
-10,175 Reduced 20.18%
40,237 $1.89 Million
Q2 2024

Aug 13, 2024

SELL
$51.17 - $68.18 $461,553 - $614,983
-9,020 Reduced 15.18%
50,412 $2.72 Million
Q1 2024

May 13, 2024

BUY
$60.67 - $89.12 $277,868 - $408,169
4,580 Added 8.35%
59,432 $4.05 Million
Q4 2023

Feb 12, 2024

BUY
$38.62 - $72.18 $1.08 Million - $2.02 Million
27,973 Added 104.07%
54,852 $3.43 Million
Q3 2023

Nov 13, 2023

SELL
$45.39 - $59.0 $89,962 - $116,938
-1,982 Reduced 6.87%
26,879 $1.22 Million
Q2 2023

Aug 14, 2023

SELL
$43.47 - $67.77 $29,646 - $46,219
-682 Reduced 2.31%
28,861 $1.62 Million
Q1 2023

May 12, 2023

SELL
$41.0 - $56.12 $17,220 - $23,570
-420 Reduced 1.4%
29,543 $1.34 Million
Q4 2022

Feb 13, 2023

BUY
$39.19 - $65.67 $31,234 - $52,338
797 Added 2.73%
29,963 $1.22 Million
Q3 2022

Nov 14, 2022

BUY
$61.1 - $83.78 $370,877 - $508,544
6,070 Added 26.28%
29,166 $1.91 Million
Q2 2022

Aug 15, 2022

SELL
$43.23 - $73.83 $455,168 - $777,356
-10,529 Reduced 31.31%
23,096 $1.4 Million
Q1 2022

May 13, 2022

BUY
$53.19 - $79.24 $225,206 - $335,502
4,234 Added 14.41%
33,625 $2.11 Million
Q4 2021

Feb 14, 2022

SELL
$70.09 - $111.29 $422,712 - $671,189
-6,031 Reduced 17.03%
29,391 $2.23 Million
Q3 2021

Nov 15, 2021

BUY
$110.2 - $156.64 $1.43 Million - $2.04 Million
13,004 Added 58.01%
35,422 $3.97 Million
Q2 2021

Aug 13, 2021

SELL
$100.84 - $161.89 $7,260 - $11,656
-72 Reduced 0.32%
22,418 $3.63 Million
Q1 2021

May 14, 2021

BUY
$110.72 - $210.04 $629,886 - $1.19 Million
5,689 Added 33.86%
22,490 $2.74 Million
Q4 2020

Feb 12, 2021

BUY
$79.67 - $173.23 $331,905 - $721,676
4,166 Added 32.97%
16,801 $2.57 Million
Q3 2020

Nov 16, 2020

BUY
$78.5 - $100.64 $58,247 - $74,674
742 Added 6.24%
12,635 $1.06 Million
Q2 2020

Aug 14, 2020

SELL
$38.5 - $76.05 $14,938 - $29,507
-388 Reduced 3.16%
11,893 $874,000
Q1 2020

May 14, 2020

BUY
$33.68 - $62.53 $24,215 - $44,959
719 Added 6.22%
12,281 $522,000
Q4 2019

Feb 13, 2020

BUY
$36.68 - $73.13 $64,813 - $129,220
1,767 Added 18.04%
11,562 $705,000
Q3 2019

Nov 13, 2019

BUY
$40.99 - $52.56 $61,116 - $78,366
1,491 Added 17.96%
9,795 $400,000
Q2 2019

Aug 14, 2019

BUY
$35.45 - $48.2 $294,376 - $400,252
8,304 New
8,304 $399,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.42B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.